Source:http://linkedlifedata.com/resource/pubmed/id/10595730
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-1-4
|
pubmed:abstractText |
A liquid chromatography-electrospray ionization tandem mass spectrometric method was developed for the simultaneous determination of losartan and its major active metabolite, EXP-3174, in human plasma. The two analytes and the internal standard (DuP-167) were extracted from plasma under acidic conditions by using solid-phase extraction cartridges containing a sorbent of copolymer, poly(divinylbenzene-co-N-vinylpyrrolidone). The analytes were separated by LC equipped with a reversed-phase C18 column, and introduced into the mass spectrometer via the electrospray ion source with pneumatically-assisted nebulization. For LC-MS-MS samples, an isocratic mobile phase consisting of [0.1% triethylamine-0.1% acetic acid (pH 7.1)]-acetonitorile (65:35, v/v) was used, and the assay was monitored for the negative fragment ions of the analytes. The method demonstrated linearity from 1 to 1000 ng/ml for both losartan and EXP-3174. The limit of quantification for both compounds in plasma was 1 ng/ml. This assay method may be useful for the measurement of levels of the two compounds in clinical studies of losartan.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/EXP3174,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Losartan,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1387-2273
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
12
|
pubmed:volume |
734
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
325-30
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10595730-Antihypertensive Agents,
pubmed-meshheading:10595730-Chromatography, Liquid,
pubmed-meshheading:10595730-Drug Stability,
pubmed-meshheading:10595730-Humans,
pubmed-meshheading:10595730-Imidazoles,
pubmed-meshheading:10595730-Losartan,
pubmed-meshheading:10595730-Mass Spectrometry,
pubmed-meshheading:10595730-Quality Control,
pubmed-meshheading:10595730-Sensitivity and Specificity,
pubmed-meshheading:10595730-Tetrazoles
|
pubmed:year |
1999
|
pubmed:articleTitle |
Method for the simultaneous determination of losartan and its major metabolite, EXP-3174, in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry.
|
pubmed:affiliation |
Drug Metabolism, Development Research Laboratories, Banyu Pharmaceutical Co., Ltd., Osato-gun, Saitama, Japan.
|
pubmed:publicationType |
Journal Article
|